🕵️ Biocardia, Inc. ($BCDA)
SEC insider & ownership activity, last 12 months · CIK 925741 · every row links its SEC filing
Over the last 12 months insiders bought $1.1M with no open-market selling against it. Simon H. Stertzer bought $602K (Sep–Jun). Thomas A. Satterfield, JR. added 8.2% → 9.9%. 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Jun 12, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $1.1M (37 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Simon H. Stertzer | 4 | $602K | 0 | – | Jun 23, 2026 |
| Blank Andrew Scott | 2 | $360K | 0 | – | Sep 19, 2025 |
| Altman Peter | 31 | $120K | 0 | – | Jul 29, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Thomas A. Satterfield, JR. | 9.9% | 13G | Aug 13, 2025 | filing ↗ | |
| Lincoln Alternative Strategies LLC | 7.5% | 13G | Sep 19, 2025 | filing ↗ | |
| Blank Andrew Scott | 5.5% | 13D | Apr 23, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Delisting notice (3.01) | Jun 12, 2026 | filing ↗ |
| Other events (8.01) | Jun 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Other events (8.01) | Apr 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 20, 2026 | filing ↗ |
| Delisting notice (3.01) | Apr 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 2, 2026 | filing ↗ |
| Earnings (2.02) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Other events (8.01) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Other events (8.01) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |